Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neurons

Neurochemistry International

Volumn 56, Issue 3, 2010, Pages 404-409

  Domoki, Ferenc ^a,b   Kis, Béla ^a,c   Gáspár, Tamás ^a   Snipes, James A ^a   Bari, Ferenc ^d   Busija, David W ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Cell culture; Intracellular calcium; Neuroprotection; Reactive oxygen species; Statins

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE; MEVALONIC ACID; ROSUVASTATIN; SUPEROXIDE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EXCITOTOXICITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FLUOROBENZENES; GLUTAMIC ACID; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIC PRECONDITIONING; MEVALONIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDATIVE STRESS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SULFONAMIDES; SUPEROXIDES; TIME FACTORS;

RATTUS;

EID: 77049114497     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.11.013     Document Type: Article

References (32)

1. Bindokas V.P., et al. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci. 1996, 16:1324-1336.
2. Bosel J., et al. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J. Neurochem. 2005, 92:1386-1398.
3. Chen J., et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 2003, 53:743-751.
4. Chobanian A.V., Hollander W. Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. J. Clin. Invest. 1962, 41:1732-1737.
5. Danielisova V., et al. Changes of endogenous antioxidant enzymes during ischemic tolerance acquisition. Neurochem. Res. 2005, 30:559-565.
6. Deadwyler S.A., et al. Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1993, 1:121-134.
7. Dietschy J.M., Turley S.D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 2004, 45:1375-1397.
8. Domoki F., et al. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am. J. Physiol. Cell Physiol. 2009, 296:C97-C105.
9. Gaspar T., et al. Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J. Neurochem. 2008, 105:1115-1128.
10. Gaspar T., et al. Neuronal preconditioning with the antianginal drug, bepridil. J. Neurochem. 2007, 102:595-608.
11. Gaspar T., et al. ROS-independent preconditioning in neurons via activation of mitoK(ATP) channels by BMS-191095. J. Cereb. Blood Flow Metab. 2008, 28:1090-1103.
12. Hayashi T., et al. HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons. Brain Res. 2005, 1037:52-58.
13. Hazell A.S. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 2007, 50:941-953.
14. Hedley D.W., Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 1994, 15:349-358.
15. Hong H., et al. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2210-H2215.
16. 2+ is coupled with reactive oxygen species generation in cultured hippocampal neurons but not in astrocytes. J. Neurosci. Res. 2005, 79:262-271.
17. Kajta M., et al. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro. Neurochem. Int. 2009, 55:265-274.
18. Kis B., et al. Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. J. Neurochem. 2003, 87:969-980.
19. Lim J.H., et al. Simvastatin prevents oxygen and glucose deprivation/reoxygenation-induced death of cortical neurons by reducing the production and toxicity of 4-hydroxy-2E-nonenal. J. Neurochem. 2006, 97:140-150.
20. Mattson M.P., et al. Developmental expression, compartmentalization, and possible role in excitotoxicity of a putative NMDA receptor protein in cultured hippocampal neurons. Brain Res. 1991, 565:94-108.
21. Mattson M.P., et al. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 1993, 121:1-13.
22. Mayanagi K., et al. Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J. Cereb. Blood Flow Metab. 2008, 28:1927-1935.
23. Misiti F., et al. Mitochondrial oxygen consumption inhibition importance for TMT-dependent cell death in undifferentiated PC12 cells. Neurochem. Int. 2008, 52:1092-1099.
24. Molz S., et al. Guanosine-5′-monophosphate induces cell death in rat hippocampal slices via ionotropic glutamate receptors activation and glutamate uptake inhibition. Neurochem. Int. 2009, 55:703-709.
25. Orr J.D. Statins in the spectrum of neurologic disease. Curr. Atheroscler. Rep. 2008, 10:11-18.
26. Ponce J., et al. Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke 2008, 39:1269-1275.
27. Roensch J., et al. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochem. Int. 2007, 50:800-806.
28. 2+ load and greater vulnerability of motor neurons in spinal cord cultures. Neurochem. Int. 2008, 52:247-255.
29. Szenasi G., et al. 2,3-Benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects. Neurochem. Int. 2008, 52:166-183.
30. Tanaka T., et al. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. J. Neurosci. 2000, 20:2852-2859.
31. Wang H., et al. Over-expression of antioxidant enzymes protects cultured hippocampal and cortical neurons from necrotic insults. J. Neurochem. 2003, 87:1527-1534.
32. Zacco A., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 2003, 23:11104-11111.